HuiDDeLaCruzMBrueraE.Palliative care for delirium in patients in the last weeks of life: the final frontier. J Palliat Care2014; 30(4): 259–264.
2.
WattCLMomoliFAnsariMT, et al. The incidence and prevalence of delirium across palliative care settings: a systematic review. Palliat Med. Epub ahead of print 11 June 2019. DOI: 10.1177/0269216319854944.
3.
HosieASiddiqiNFeathersoneI, et al. Inclusion, characteristics and outcomes of people requiring palliative care in studies of non-pharmacological interventions for delirium: a systematic review. Palliat Med, in press.
4.
LawlorPGGagnonBManciniIL, et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med2000; 160(6): 786–794.
5.
TayjasanantSBrueraEHuiD.How far along the disease trajectory? An examination of the time-related patient characteristics in the palliative oncology literature. Supp Care Cancer2016; 24: 3997–4004.
6.
HuiDFrisbee-HumeSWilsonA, et al. Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care: a randomized clinical trial. JAMA2017; 318(11): 1047–1056.
7.
BarnardNDWillettWCDingEL.The misuse of meta-analysis in nutrition research. JAMA2017; 318(15): 1435–1436.
8.
HuiDHannonBLZimmermannC, et al. Improving patient and caregiver outcomes in oncology: team-based, timely, and targeted palliative care. CA Cancer J Clin2018; 68(5): 356–376.